Oral encapsulated transforming growth factor ß1 reduces endogenous levels: Effect on inflammatory bowel disease.

Hammer, Laura; Furtado, Stacia; Mathiowitz, Edith; Auci, Dominick L

Hammer, Laura; Furtado, Stacia; Mathiowitz, Edith; Auci, Dominick L.

Afiliación

Hammer L; Department of Research and Development, TherapyX, Buffalo, NY 14214, United States.
Furtado S; Department of Research and Development, TherapyX, Buffalo, NY 14214, United States.
Mathiowitz E; Department of Molecular Pharmacology, Brown University, Providence, RI 02912, United States.
Auci DL; Department of Research and Development, TherapyX, Buffalo, NY 14214, United States. dauci@therapyxinc.com.

World J Gastrointest Pharmacol Ther ; 11(5): 79-92, 2020 Nov 08.

Article en En | MEDLINE | ID: mdl-33251033

Palabras clave

All trans retinoic acid; Crohn's disease; Inflammatory bowel disease; Regulatory T cells; Transforming growth factor beta; Ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Gastrointest Pharmacol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google